230 related articles for article (PubMed ID: 30398935)
1. Uncontrolled gelatin degradation in non-healing chronic wounds.
Trøstrup H; Holstein P; Karlsmark T; Moser C; Ågren MS
J Wound Care; 2018 Nov; 27(11):724-734. PubMed ID: 30398935
[TBL] [Abstract][Full Text] [Related]
2. S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus.
Trøstrup H; Holstein P; Christophersen L; Jørgensen B; Karlsmark T; Høiby N; Moser C; Ågren MS
Arch Dermatol Res; 2016 Jul; 308(5):347-55. PubMed ID: 27084691
[TBL] [Abstract][Full Text] [Related]
3. [Protein expressions of matrix metalloproteinase-9 and its inhibitor and their ratio changes in wound healing of patients with stages Ⅲ and Ⅳ pressure ulcers].
Wang Y; Li X; Zhao W; Gao ZZ; Zheng MJ; Pang YL; Chen ZY
Zhonghua Shao Shang Za Zhi; 2019 Oct; 35(10):746-751. PubMed ID: 31658546
[No Abstract] [Full Text] [Related]
4. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
[TBL] [Abstract][Full Text] [Related]
5. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing.
Wysocki AB; Kusakabe AO; Chang S; Tuan TL
Wound Repair Regen; 1999; 7(3):154-65. PubMed ID: 10417751
[TBL] [Abstract][Full Text] [Related]
6. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers.
Ladwig GP; Robson MC; Liu R; Kuhn MA; Muir DF; Schultz GS
Wound Repair Regen; 2002; 10(1):26-37. PubMed ID: 11983004
[TBL] [Abstract][Full Text] [Related]
7. Induction of MMP-1, MMP-3 and TIMP-1 in normal dermal fibroblasts by chronic venous leg ulcer wound fluid*.
Subramaniam K; Pech CM; Stacey MC; Wallace HJ
Int Wound J; 2008 Mar; 5(1):79-86. PubMed ID: 18336381
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
Trengove NJ; Stacey MC; MacAuley S; Bennett N; Gibson J; Burslem F; Murphy G; Schultz G
Wound Repair Regen; 1999; 7(6):442-52. PubMed ID: 10633003
[TBL] [Abstract][Full Text] [Related]
9. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers.
Nwomeh BC; Liang HX; Cohen IK; Yager DR
J Surg Res; 1999 Feb; 81(2):189-95. PubMed ID: 9927539
[TBL] [Abstract][Full Text] [Related]
10. Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers.
Li Z; Guo S; Yao F; Zhang Y; Li T
J Diabetes Complications; 2013; 27(4):380-2. PubMed ID: 23357650
[TBL] [Abstract][Full Text] [Related]
11. Chronic venous disease - Part II: Proteolytic biomarkers in wound healing.
Ligi D; Mosti G; Croce L; Raffetto JD; Mannello F
Biochim Biophys Acta; 2016 Oct; 1862(10):1900-8. PubMed ID: 27460704
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing.
Muller M; Trocme C; Lardy B; Morel F; Halimi S; Benhamou PY
Diabet Med; 2008 Apr; 25(4):419-26. PubMed ID: 18387077
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients.
Lobmann R; Ambrosch A; Schultz G; Waldmann K; Schiweck S; Lehnert H
Diabetologia; 2002 Jul; 45(7):1011-6. PubMed ID: 12136400
[TBL] [Abstract][Full Text] [Related]
14. TIMP-1, MMP-2, MMP-9, and PIIINP as serum markers for skin fibrosis in patients following severe burn trauma.
Ulrich D; Noah EM; von Heimburg D; Pallua N
Plast Reconstr Surg; 2003 Apr; 111(4):1423-31. PubMed ID: 12618601
[TBL] [Abstract][Full Text] [Related]
15. An MMP/TIMP ratio scoring system as a potential predictive marker of diabetic foot ulcer healing.
Luanraksa S; Jindatanmanusan P; Boonsiri T; Nimmanon T; Chaovanalikit T; Arnutti P
J Wound Care; 2018 Dec; 27(12):849-855. PubMed ID: 30557113
[TBL] [Abstract][Full Text] [Related]
16. S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling.
Trøstrup H; Lundquist R; Christensen LH; Jorgensen LN; Karlsmark T; Haab BB; Agren MS
Br J Dermatol; 2011 Aug; 165(2):292-301. PubMed ID: 21517798
[TBL] [Abstract][Full Text] [Related]
17. [Dynamic changes of MMP-1, MMP-9 and TIMP-1 in the refractory diabetic dermal ulcers treated by autologous Platelet-rich gel].
He LP; Wang C; Chen DW; Li XJ; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):757-61. PubMed ID: 23230755
[TBL] [Abstract][Full Text] [Related]
18. Potential role of metalloproteinase inhibitors from radiation‑sterilized amnion dressings in the healing of venous leg ulcers.
Litwiniuk M; Bikowska B; Niderla-Bielińska J; Jóźwiak J; Kamiński A; Skopiński P; Grzela T
Mol Med Rep; 2012 Oct; 6(4):723-8. PubMed ID: 22798012
[TBL] [Abstract][Full Text] [Related]
19. Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers.
Liu Y; Min D; Bolton T; Nubé V; Twigg SM; Yue DK; McLennan SV
Diabetes Care; 2009 Jan; 32(1):117-9. PubMed ID: 18835949
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with incisional hernia.
Henriksen NA; Sørensen LT; Jorgensen LN; Agren MS
Wound Repair Regen; 2013; 21(5):661-6. PubMed ID: 23927724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
